Olaratumab
Definition: Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. source: Wikipedia
- ID
- 776979009
- Name
- Olaratumab
- Previous ID
- 34002311000001106
- ID date
- 6 Feb 2023